James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.
The 2022 MIT Japan Conference will feature presentations by MIT-connected startups in a variety of areas, with technology and business scopes applicable to Japan.
P&G Ventures would like to explore enabling technologies for jobs-to-be-done in the Food Cycle Management space.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
P&G is looking for new solutions that can help them capture and leverage massive amounts of first-party consumer data to drive lasting, 1:1 relationships with consumers.
Presentation opportunity in Japan and Korea.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.